Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19

Journal of Experimental Medicine

Volumn 188, Issue 1, 1998, Pages 145-155

  Fehr, Thomas ^a   Rickert, Robert C ^b   Odermatt, Bernhard ^a   Roes, Jürgen ^b   Rajewsky, Klaus ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antiviral immunity; B cell memory; CD19; Complement; Germinal center

Indexed keywords

CD19 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; GERMINAL CENTER; HOST RESISTANCE; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES; ANTIGENS, CD19; ANTIGENS, VIRAL; B-LYMPHOCYTES; GERMINAL CENTER; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT 3D; RHABDOVIRIDAE; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0032490642     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.1.145     Document Type: Article

References (73)

1. Stashenko, P., L.M. Nadler, R. Hardy, and S.F. Schlossman. 1981. Expression of cell surface markers after human B lymphocyte activation. Proc. Natl. Acad. Sci. USA. 78:3848-3852.
2. Uckun, F.M., W.E. Evans, C.J. Forsyth, K.G. Waddick, L.T. Ahlgren, L.M. Chelstrom, A. Burkhardt, J. Bolen, and D.E. Myers. 1995. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science. 267:886-891.
3. Tedder, T.F., and C.M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 143:712-717.
4. Zhou, L.J., D.C. Ord, A.L. Hughes, and T.F. Tedder. 1991. Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain. J. Immunol. 147:1424-1432.
5. Myers, D.E., X. Jun, K.G. Waddick, C. Forsyth, L.M. Chelstrom, R.L. Gunther, N.E. Tumer, J. Bolen, and F.M. Uckun. 1995. Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells. Proc. Natl. Acad. Sci. USA. 92:9575-9579.
6. Chalupny, N.J., A. Aruffo, J.M. Esselstyn, P.Y. Chan, J. Bajorath, J. Blake, L.K. Gilliland, J.A. Ledbetter, and M.A. Tepper. 1995. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 25:2978-2984.
7. Weng, W.K., L. Jarvis, and T.W. LeBien. 1994. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514-32521.
8. Carter, R.H., D.A. Tuveson, D.J. Park, S.G. Rhee, and D.T. Fearon. 1991. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:3663-3671.
9. Uckun, F.M., A.L. Burkhardt, L. Jarvis, X. Jun, B. Stealey, I. Dibirdik, D.E. Myers, L. Tuel-Ahlgren, and J.B. Bolen. 1993. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 268:21172-21184.
10. Bradbury, L.E., V.S. Goldmacher, and T.F. Tedder. 1993. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13. J. Immunol. 151:2915-2927.
11. Matsumoto, A.K., J. Kopicky-Burd, R.H. Carter, D.A. Tuveson, T.F. Tedder, and D.T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55-64.
12. Bradbury, L.E., G.S. Kansas, S. Levy, R.L. Evans, and T.F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841-2850.
13. Pesando, J.M., L.S. Bouchard, and B.E. McMaster. 1989. CD19 is functionally and physically associated with surface immunoglobulin. J. Exp. Med. 170:2159-2164.
14. Carter, R.H., G.M. Doody, J.B. Bolen, and D.T. Fearon. 1997. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J. Immunol. 158:3062-3069.
15. Sato, S., N. Ono, D.A. Steeber, D.S. Pisetsky, and T.F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371-4378.
16. Krop, I., A.R. de Fougerolles, R.R. Hardy, M. Allison, M.S. Schlissel, and D.T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238-242.
17. Rickert, R.C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:352-355.
18. Engel, P., L.J. Zhou, D.C. Ord, S. Sato, B. Koller, and T.F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:39-50.
19. Kansas, G.S., and T.F. Tedder. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosme kinase-dependent pathway. J. Immunol. 147:4094-4102.
20. Carter, R.H., and D.T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:105-107.
21. Pepys, M.B. 1974. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140:126-145.
22. Matsuda, T., G.P. Martinelli, and A.G. Osler. 1978. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide. J. Immunol. 121:2048-2051.
23. O'Neil, K.M., H.D. Ochs, S.R. Heller, L.C. Cork, J.M. Morris, and J.A. Winkelstein. 1988. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J. Immunol. 140:1939-1945.
24. Cochrane, C.G., H.J. Muller-Eberhard, and B.S. Aikin. 1970. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immunol. 105:55-69.
25. Heyman, B., E.J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665-668.
26. Thyphronitis, G., T. Kinoshita, K. Inoue, J.E. Schweinle, G.C. Tsokos, E.S. Metcalf, F.D. Finkelman, and J.E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224-230.
27. Hebell, T., J.M. Ahearn, and D.T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science. 254:102-105.
28. Wessels, M.R., P. Butko, M. Ma, H.B. Warren, A.L. Lage, and M.C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA. 92: 11490-11494.
29. Ahearn, J.M., M.B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R.G. Howard, T.L. Rothstein, and M.C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:251-262.
30. Molina, H., V.M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R.W. Karr, and D.D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA. 93:3357-3361.
31. Fehr, T., M.F. Bachmann, H. Bluethmann, H. Kikutani, H. Hengartner, and R.M. Zinkernagel. 1996. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell. Immunol. 168:184-192.
32. Mills, B.J., and N.R. Cooper. 1978. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements. J. Immunol. 121:1549-1557.
33. Van Noesel, C.J., A.C. Lankester, and R.A. Van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today. 14:8-11.
34. Dempsey, P.W., E.D. Allison, S. Akkaraju, C.C. Goodnow, and D.T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:348-350.
35. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science. 272:50-53.
36. Sato, S., D.A. Steeber, and T.F. Tedder. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA. 92:11558-11562.
37. Zhou, L.J., H.M. Smith, T.J. Waldschmidt, R. Schwarting, J. Daley, and T.F. Tedder. 1994. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell. Biol. 14: 3884-3894.
38. Bachmann, M.F., H. Hengartner, and R.M. Zinkernagel. 1997. Neutralizing anti-viral B cell responses. Annu. Rev. Immunol. 15:235-270.
39. Zinkernagel, R.M. 1996. Immunology taught by viruses. Science. 271:173-178.
40. Fields, B.N. 1990. Virology. Lippincott-Raven Publishers, New York. 1267 pp.
41. Matsuura, Y., R.D. Possee, H.A. Overton, and D.H. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250.
42. Bachmann, M.F., T.M. Kündig, C.P. Kalberer, H. Hengartner, and R.M. Zinkernagel. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell-but not T-help-independent B-cell responses. J. Virol. 67:3917-3922.
43. Wagner, R.R., R.M. Snyder, and S. Yamazaki. 1970. Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J. Virol. 5:548-558.
44. Scott, D.W., and R.K. Gershon. 1970. Determination of total and mercaptoethanol-resistant antibody in the same serum sample. Clin. Exp. Immunol. 6:313-316.
45. Moskophidis, D., and F. Lehmann-Grube. 1984. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. J. Immunol. 133: 3366-3370.
46. Bachmann, M.F., T.M. Kündig, B. Odermatt, H. Hengartner, and R.M. Zinkernagel. 1994. Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J. Immunol. 153:3386-3397.
47. Bachmann, M.F., B. Odermatt, H. Hengartner, and R.M. Zinkernagel. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-2269.
48. Gray, D., M. Kosco, and B. Stockinger. 1991. Novel pathways of antigen presentation for the maintenance of memory. Int. Immunol. 3:141-148.
49. Bachmann, M.F., H. Hengartner, and K.M. Zinkernagel. 1995. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 25:3445-3451.
50. Leist, T.P., S.P. Cobbold, H. Waldmann, M. Aguet, and R.M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
51. Thornton, B.P., V. Vetvicka, and G.D. Ross. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727-1737.
52. Lankester, A.C., P.M.L. Rood, G.M.W. van Schijndel, B. Hooibrink, A.J. Verhoeven, and K.A.W. van Lier. 1996. Alteration of B-cell antigen receptor signaling by CD19 co-ligation. A study with bispecific antibodies. J. Biol. Chem. 271: 22326-22330.
53. Klaus, G.G., and J.H. Humphrey. 1977. The generation of memory cells. I. The role of G3 in the generation of B memory cells. Immunology. 33:31-40.
54. Wiersma, E.J., T. Kinoshita, and B. Heyman. 1991. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur. J. Immunol. 21:2501-2506.
55. Van den Berg, T.K., E.A. Dopp, M.R. Daha, G. Kraal, and C.D. Dijkstra. 1992. Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur. J. Immunol. 22:957-962.
56. Bachmann, M.F., U.H. Rohrer, U. Steinhoff, K. Bürki, S. Skuntz, H. Arnheiter, H. Hengartner, and R.M. Zinkernagel. 1994. T helper cell unresponsiveness: rapid induction in antigen-transgenic and reversion in non-transgenic mice. Eur. J. Immunol. 24:2966-2973.
57. Bachmann, M.F., U.H. Rohrer, T.M. Kündig, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1993. The influence of antigen organization on B cell responsiveness. Science. 262: 1448-1451.
58. Bachmann, M.F., T. Fehr, G. Freer, H. Hengartner, and R.M. Zinkernagel. 1997. Correlation of tolerogenicity of a viral antigen with its immunogenicity. J. Immunol. 158:5106-5111.
59. Fischer, M.B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R.G. Howard, T.L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549-556.
60. Croix, D.A., J.M. Ahearn, A.M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M.C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857-1864.
61. Tew, J.G., R.P. Phipps, and T.E. Mandel. 1980. The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol. Rev. 53:175-201.
62. Ramshaw, I., J. Ruby, A. Ramsay, G. Ada, and G. Karupiah. 1992. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo. Immunol. Rev. 127:157-182.
63. Fearon, D.T. 1993. The CD19-CR2-TAP-1 complex. CD45 and signaling by the antigen receptor of B lymphocytes. Curr. Biol. 5:341-348.
64. Holder, M.J., K. Knox, and J. Gordon. 1992. Factors modifying survival pathways or germinal center B cells. Glucocorticoids and transforming growth factor-β, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur. J. Immunol. 22:2725-2728.
65. Herzenberg, L.A., P.A. Lalor, and A.M. Stall. 1989. Are Ly-1 B cells important in autoimmune disease? J. Autoimmun. 2(Suppl.):225-231.
66. Kelsoe, G. 1995. In situ studies of the germinal center reaction. Adv. Immunol. 60:267-288.
67. Kosco-Vilbois, M.H., H. Zentgraf, J. Gerdes, and J.Y. Bonnefoy. 1997. To "B" or not to "B" a germinal center? Immunol. Today. 18:225-230.
68. Pulendran, B., R. van Driel, and G.J. Nossal. 1997. Immunological tolerance in germinal centres. Immunol. Today. 18:27-32.
69. Lui, Y.J., J. Zhang, P.J. Lane, E.Y. Chan, and I.C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21:2951-2962. (See published erratum 22:615.)
70. Miller, C., and G. Kelsoe. 1995. Ig VH hypermutation is absent in the germinal centers of aged mice. J. Immunol. 155: 3377-3384.
71. Han, S., K. Hathcock, B. Zheng, T.B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556-567.
72. Mangeney, M., Y. Richard, D. Coulaud, T. Tursz, and J. Wiels. 1991. CD77: an antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21:1131-1140.
73. Maloney, M.D., and C.A. Lingwood. 1994. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 180:191-201.